SUBSTANCE USE AND DEPRESSION AMONG PATIENTS ADHERENT AND NON-ADHERENT TO ANTIRETROVIRAL THERAPY
- Authors: Ustinov A.S1, Pecoraro A.2,3, Mimiaga M.4,5, O’Cleirigh C.6,7, Safren S.6,7, Blokhina E.A8, Verbitskaya E.V8, Yaroslavtseva T.S8, Lioznov D.A9,10, Suvorova A.V11, Grinenko A.Y.8, Zvartau E.E.8, Krupitsky E.M12,13, Woody G.E2,3
-
Affiliations:
- Bekhterev Research Psychoneurological Institute
- 1) University of Pennsylvania
- 2) NIDA Clinical Trials Network, Delaware Valley Node
- 1)Harvard School of Public Health
- 2) Harvard Medical School
- 1) Harvard Medical School
- 2) Massachusetts General Hospital
- First Pavlov State Medical University
- 1) First Pavlov State Medical University
- 2) Pasteur St. Petersburg Scientific Research Institute of Epidemiology and Microbiology
- St. Petersburg Institute for Informatics and Automation of the Russian Academy of Sciences (SPIIRAS)
- 1) Bekhterev Research Psychoneurological Institute
- 2) First Pavlov State Medical University
- Issue: Vol XLVIII, No 2 (2016)
- Pages: 5-11
- Section: Articles
- URL: https://journals.rcsi.science/1027-4898/article/view/13976
- DOI: https://doi.org/10.17816/nb13976
- ID: 13976
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Andrey S Ustinov
Bekhterev Research Psychoneurological Institute
Email: andrey.ustinov29@gmail.com
192019, St. Petersburg, Bekhterev str., 3
Anna Pecoraro
1) University of Pennsylvania; 2) NIDA Clinical Trials Network, Delaware Valley Node1) School of Medicine Philadelphia, PA, USA
Matthew Mimiaga
1)Harvard School of Public Health; 2) Harvard Medical SchoolBoston, MA, USA
Conall O’Cleirigh
1) Harvard Medical School; 2) Massachusetts General HospitalBoston, MA, USA
Steven Safren
1) Harvard Medical School; 2) Massachusetts General HospitalBoston, MA, USA
Elena A Blokhina
First Pavlov State Medical UniversityValdman Institute of Pharmacology 197022, St. Petersburg, L. Tolstoi str., 6-8
Elena V Verbitskaya
First Pavlov State Medical UniversityValdman Institute of Pharmacology 197022, St. Petersburg, L. Tolstoi str., 6-8
Tatyana S Yaroslavtseva
First Pavlov State Medical UniversityValdman Institute of Pharmacology 197022, St. Petersburg, L. Tolstoi str., 6-8
Dmitriy A Lioznov
1) First Pavlov State Medical University; 2) Pasteur St. Petersburg Scientific Research Institute of Epidemiology and Microbiology1) кафедра инфекционных болезней и эпидемиологии 1) 197022, St. Petersburg, L. Tolstoi str., 6-8; 2) 197101, St. Petersburg, Mira str., 14
Alena V Suvorova
St. Petersburg Institute for Informatics and Automation of the Russian Academy of Sciences (SPIIRAS)1999178, St. Petersburg, line 14, 39
Alexandr Ya Grinenko
First Pavlov State Medical UniversityValdman Institute of Pharmacology 197022, St. Petersburg, L. Tolstoi str., 6-8
Edwin Eduardovich Zvartau
First Pavlov State Medical UniversityValdman Institute of Pharmacology 197022, St. Petersburg, L. Tolstoi str., 6-8
Evgeny M Krupitsky
1) Bekhterev Research Psychoneurological Institute; 2) First Pavlov State Medical University2) Valdman Institute of Pharmacology 1) 192019, St. Petersburg, Bekhterev str., 3; 2) 197022, St. Petersburg, L. Tolstoi str., 6-8
George E Woody
1) University of Pennsylvania; 2) NIDA Clinical Trials Network, Delaware Valley Node1) School of Medicine Philadelphia, PA, USA
References
- Андрющенко А.В., Дроюижев М.Ю., Добровольский А.В. Сравнительная оценка шкал CES-D, BDI и HADS(D) в диагностике депрессий в общемедицинской практике // Журнал неврологии и психиатрии им. С.С. Корсакова. 2003. Т. 5. С. 11-18.
- Устинов А.С. , Суворова А. В., Беляков Н. А. и др. Влияние психопатологической симптоиатики и употребления психоактивных веществ на уровень вирусной нагрузки ВИЧ у больных, получающих АРВТ // ВИЧ-инфекция и имуносупрессия. 2015. Т. 7. № 2. С. 41-48.
- Справка. ВИЧ-инфекция в Российской Федерации на 1 ноября 2015 г. / http://antispidnn.ru/spravka-po-vich-infekcii-v-rossijskoj-federacii-01-11-2015/.
- Aleman S. Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy // AIDS. 2002. Vol. 16, № 7. P. 1039-1044.
- Anderson L.A. Dedrick R. F. Development of the Trust in Physician scale: a measure to assess interpersonal trust in patient-physician relationships // Psychol. Rep. 1990. Vol. 67, № 3, Pt 2. P. 1091-1100.
- Beck A.T. Kovacs M., Weissman A. Hopelessness and suicidal behavior. An overview // JAMA. 1975. Vol. 234, № 11. P. 1146-1149.
- Chesney M.A. The elusive gold standard. Future perspectives for HIV adherence assessment and intervention // J. Acquir. Immune Defic. Syndr. 2006. Vol. 43, Suppl 1. P. S149-S155.
- Krupitsky E. Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available // Curr. Psychiatry Rep. 2010. Vol. 12, № 5. P. 448-453.
- Lima V.D., Harrigan R., Bangsberg D.R. et al. Montaner The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time // J. Acquir. Immune Defic. Syndr. 2009. Vol. 50, № 5. P. 529-536.
- McLellan A.T., Kushner H., Metzger D. et al. // J. Subst. Abuse Treat. 1992. Vol. 9. P. 199-213.
- Miller W.R., Rollnick S. Motivational Interviewing: Helping People Change. NY: Guilford Press, 2012. 482 p.
- Parkin N.T. Deeks S. G., Wrin M. T. et al. Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patients // AIDS. 2000. Vol. 14. P. 2877-2887.
- Paterson D.L., Swindells S., Mohr J. et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection // Ann. Intern. Med. 2000. Vol. 133. P. 21-30.
- Pecoraro A. Royer-Malvestuto C., Rosenwasser B. et al. Factors contributing to dropping out from and returning to HIV treatment in inner city primary care HIV clinic in the United States // AIDS Care. 2013. Vol. 25. P. 1399-1406.
- Radloff L.S. The CES-D Scale: A Self-Report Depression Scale for Research in the General Population // Appl. Psychol. Meas. 1977. Vol. 1, № 3. P. 385-401.